ArticleEuropean journal of rheumatology2022

Ruxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still's Disease.

Ofer Levy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.